NHS strikes landmark deal for drug to treat two most common cancers

Hundreds of patients with breast cancer and advanced prostate cancer could benefit from a breakthrough targeted therapy, after the NHS agreed a landmark commercial deal to roll-out the drug to treat forms of the two most common cancers in England. The drug, olaparib (Lynparza®), targets cancers with mutations in the BRCA genes, and works by […]

Read more

NHS on-the-spot liver scans find one in 10 people have liver damage that could lead to deadly cancer

A new initiative to check for liver cancer in high-risk communities has been rolled out as part of a major NHS drive to catch more cancers earlier and save lives. The roaming trucks performed more than 7,000 fibroscans and identified over 830 people with cirrhosis or advanced fibrosis, a leading cause of liver cancer, in […]

Read more